The most advanced treatments for monkeypox were developed to address the wrong threat ...Middle East

Quartz - Economy
The most advanced treatments for monkeypox were developed to address the wrong threat
The markets may be in free fall, but a few biotechnology companies had an exceptionally good day. Siga’s stock is up more than 40%; Emergent Biosolutions’s gained nearly 12%, and Tonix Pharmaceutical, 15%. Outside the US, Danish Bavarian Nordic jumped 19%.The reason? They make treatments for monkeypox.A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge. With covid still very much ongoing and fresh memories of early 2020, the alert has gone up quickly, lifting the shares of makers of the medications that would be needed to treat a monkeypox outbreak.Read the rest of this story on qz.com. Become a member t

Hence then, the article about the most advanced treatments for monkeypox were developed to address the wrong threat was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The most advanced treatments for monkeypox were developed to address the wrong threat )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News